Aptose Biosciences Market Cap

Aptose Biosciences has a market cap or net worth of $2.04 million as of June 27, 2025. Its market cap has decreased by -88.49% in one year.

Market Cap

2.04M

Enterprise Value

6.67M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.82

Market Cap Chart

Since May 31, 1994, Aptose Biosciences's market cap has decreased from 34.16M to 2.04M, a decrease of -94.04%. That is a compound annual growth rate of -8.67%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	2.04M	-85.01%
Dec 31, 2024	13.59M	-32.53%
Dec 29, 2023	20.15M	-62.12%
Dec 30, 2022	53.19M	-56.27%
Dec 31, 2021	121.64M	-68.80%
Dec 31, 2020	389.84M	-9.61%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Elite Pharmaceuticals	779.84M
Veradigm	755.74M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
American Oncology Network	414.48M
Glass House Brands	405.91M
CytoDyn	375.37M

Market Cap Rankings